| Literature DB >> 35615750 |
Natalie DelRocco1, Yipeng Wang1, Dongyuan Wu1, Yuting Yang1, Guogen Shan1,2.
Abstract
Biomedical studies, such as clinical trials, often require the comparison of measurements from two correlated tests in which each unit of observation is associated with a binary outcome of interest via relative risk. The associated confidence interval is crucial because it provides an appreciation of the spectrum of possible values, allowing for a more robust interpretation of relative risk. Of the available confidence interval methods for relative risk, the asymptotic score interval is the most widely recommended for practical use. We propose a modified score interval for relative risk and we also extend an existing nonparametric U-statistic-based confidence interval to relative risk. In addition, we theoretically prove that the original asymptotic score interval is equivalent to the constrained maximum likelihood-based interval proposed by Nam and Blackwelder. Two clinically relevant oncology trials are used to demonstrate the real-world performance of our methods. The finite sample properties of the new approaches, the current standard of practice, and other alternatives are studied via extensive simulation studies. We show that, as the strength of correlation increases, when the sample size is not too large the new score-based intervals outperform the existing intervals in terms of coverage probability. Moreover, our results indicate that the new nonparametric interval provides the coverage that most consistently meets or exceeds the nominal coverage probability.Entities:
Keywords: Confidence interval; Continuity correction; Nonparametric method; Paired data; Relative risk; Wilson score interval
Year: 2022 PMID: 35615750 PMCID: PMC9122488 DOI: 10.1007/s12561-022-09345-7
Source DB: PubMed Journal: Stat Biosci ISSN: 1867-1764
Observed counts of the paired study are shown with the corresponding probabilities in parentheses
| Test 1 | Test 2 | ||
|---|---|---|---|
| Event | Nonevent | Total | |
| Event | |||
| Nonevent | |||
| Total | |||
Fig. 1Coverage probabilities for eight confidence intervals for correlated relative risk by study sample size
Fig. 2Coverage probabilities for eight confidence intervals for correlated relative risk by correlation between test 1 and test 2
Fig. 3Average confidence interval lengths for eight confidence intervals for correlated relative risk by correlation between test 1 and test 2
Fig. 4Coverage probabilities for eight confidence intervals for correlated relative risk by study sample size
Fig. 5Coverage probabilities for eight confidence intervals for correlated relative risk by true relative risk
Fig. 6Mean squared deviation of the average coverage probability from the nominal 95% coverage (MSE) and the proportion of cases with average coverage probability exceeding the nominal 95% for five confidence intervals for correlated relative risk by study sample size
Observed counts of pediatric airway hyper-responsiveness (AHR) before and after stem cell transplant (SCT)
| Pre-SCT | Post-SCT | ||
|---|---|---|---|
| AHR | No AHR | Total | |
| AHR | 1 | 1 | 2 |
| No AHR | 7 | 12 | 19 |
| Total | 8 | 13 | 21 |
CI lengths for for the AHR pre- and post-SCT study
| Method | 95% CI | ||
|---|---|---|---|
| Lower limit | Upper limit | Width | |
| Asymptotic score | 0.0653 | 0.9069 | 0.8416 |
| ASCC-L | 0.0628 | 0.9167 | 0.8539 |
| ASCC-M | 0.0603 | 0.9265 | 0.8662 |
| ASCC-H | 0.0555 | 0.9461 | 0.8906 |
| Wald asymptotic | 0.0625 | 0.9996 | 0.9371 |
| Bonett–price hybrid Wilson score | 0.0677 | 0.9227 | 0.8550 |
| MOVER Wilson score | 0.0686 | 0.8695 | 0.8008 |
| Nonparametric method | 0.0551 | 1.1333 | 1.0781 |
Diagnostic accuracy of DBT compared to standard of care
| DBT | Invasive cancer or DCIS | ||
|---|---|---|---|
| Present | Absent | Total | |
| Positive | 9 | 36 | 45 |
| Negative | 14 | 1371 | 1385 |
| Total | 23 | 1407 | 1430 |
Diagnostic accuracy of AB-MRI compared to standard of care
| AB-MRI | Invasive cancer or DCIS | ||
|---|---|---|---|
| Present | Absent | Total | |
| Positive | 22 | 187 | 209 |
| Negative | 1 | 1220 | 1221 |
| Total | 23 | 1407 | 1430 |
CI lengths for for the breast cancer detection study comparing DBT to SOC
| Method | 95% CI | ||
|---|---|---|---|
| Lower limit | Upper limit | Width | |
| Asymptotic score | 1.2795 | 3.0274 | 1.7479 |
| ASCC-L | 1.2794 | 3.0275 | 1.7481 |
| ASCC-M | 1.2794 | 3.0276 | 1.7482 |
| ASCC-H | 1.2792 | 3.0278 | 1.7486 |
| Wald asymptotic | 1.2717 | 3.0100 | 1.7383 |
| Bonett–price hybrid Wilson score | 1.2744 | 3.0037 | 1.7293 |
| MOVER Wilson score | 1.2705 | 2.9880 | 1.7175 |
| Nonparametric method | 1.2711 | 3.0116 | 1.7405 |
CI lengths for for the breast cancer detection study comparing AB-MRI to SOC
| Method | 95% CI | ||
|---|---|---|---|
| Lower limit | Upper limit | Width | |
| Asymptotic score | 6.2443 | 13.4526 | 7.2083 |
| ASCC-L | 6.2443 | 13.4527 | 7.2085 |
| ASCC-M | 6.2442 | 13.4528 | 7.2086 |
| ASCC-H | 6.2441 | 13.4531 | 7.2090 |
| Wald asymptotic | 6.1671 | 13.3892 | 7.2220 |
| Bonett–price hybrid Wilson score | 6.1815 | 13.3580 | 7.1764 |
| MOVER Wilson score | 6.1704 | 13.3173 | 7.1469 |
| Nonparametric method | 6.1643 | 13.3954 | 7.2311 |